{"id":"W2761236690","doi":"10.1182/blood-2017-07-731588","title":"FCR achieves long-term durable remissions in patients with IGHV-mutated CLL","year":2017,"lang":"en","type":"review","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; Impact","funders":"","keywords":"IGHV@; Chemoimmunotherapy; Fludarabine; Chronic lymphocytic leukemia; Rituximab; Medicine; Internal medicine; Cyclophosphamide; Oncology; Alemtuzumab; Progression-free survival; Leukemia; Immunology; Chemotherapy; Transplantation; Lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002554245,0.0006260918,0.003814659,0.002190844,0.0002389959,0.001116305,0.0007932947,0.001089857,0.00379812],"category_scores_gemma":[0.006733136,0.0003146035,0.003650016,0.001938357,0.0003965482,0.0008192444,0.0005479818,0.0009065753,0.0002367312],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009687011,"about_ca_system_score_gemma":0.001551191,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001924251,"about_ca_topic_score_gemma":0.004760052,"domain_scores_codex":[0.9986645,0.0005691473,0.0003766527,0.0001206307,0.0002181649,0.00005080986],"domain_scores_gemma":[0.9970351,0.002125503,0.0005390177,0.0000358373,0.000210068,0.00005448004],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002303095,0.00005619434,0.0004989614,0.74493,0.01094861,0.0001116607,0.0001222188,0.0002244943,0.0008208158,0.00054253,0.003246064,0.2361954],"study_design_scores_gemma":[0.007337286,0.003263079,0.01122508,0.6804006,0.1636712,0.001507658,0.0005227901,0.0003321258,0.002136276,0.001811794,0.1277103,0.00008173844],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001111363,0.9983279,0.00003711539,0.0001044359,0.00004610692,0.00003904708,0.00006944504,0.000003284557,0.0002613259],"genre_scores_gemma":[0.02017073,0.9788847,0.0002375598,0.0003848183,0.00005713312,0.00006820277,0.00008066549,0.000002956457,0.0001132701],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003814659,"threshold_uncertainty_score":0.01350826,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06436159046231887,"score_gpt":0.3778367711414914,"score_spread":0.3134751806791726,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}